Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag A small Ottawa study found psilocybin microdoses significantly reduced depression and anxiety in palliative care patients, including those with advanced ALS, with 62% showing over 50% symptom improvement and no serious side effects.

flag A small Ottawa study found that microdoses of psilocybin significantly reduced depression and anxiety in palliative care patients, including those with advanced ALS. flag Of 20 participants, 62% saw over 50% improvement in depression symptoms with no serious side effects. flag The treatment offered rapid relief for existential distress, a common but hard-to-treat issue at end-of-life, and helped some patients like ALS patient Andrew Chernysh regain a sense of meaning and hope. flag While psilocybin remains illegal in most contexts, researchers say the results suggest it could be a promising, scalable option for managing emotional suffering in dying patients, warranting further study.

8 Articles